Brittany Snider, DO
Physical Medicine & Rehabilitation · Rochester, MNNPI 1003200304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations.
Across 44 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$212
- AbbVie$203
- Amgen$125
- Merz Pharmaceuticals, LLC$118
- Azurity Pharmaceuticals, Inc.$48
- C. R. Bard, Inc. & Subsidiaries$34
- plus $154 from 7 others
What the payments were for
- Food & beverage$894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 11 | $212 |
| AbbVie(2 entities) | 13 | $203 |
| Amgen | 1 | $125 |
| Merz Pharmaceuticals, LLC | 6 | $118 |
| Azurity Pharmaceuticals, Inc. | 3 | $48 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $34 |
| Vertex | 2 | $29 |
| Bioventus LLC | 1 | $29 |
| Dentsply IH AB | 1 | $26 |
| Merz North America, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$125
How this compares
$894 in reported general payments places this provider in the 85th percentile of 196 physical medicine & rehabilitation providers in Minnesota.
See all physical medicine & rehabilitation providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $7,641 |
| Baclofen | 99 | $3,687 |
| Gabapentin | 105 | $1,405 |
| Pregabalin | 64 | $1,345 |
| Oxybutynin Chloride | 12 | $496 |
| Tizanidine Hcl | 16 | $384 |
| Duloxetine Hcl | 18 | $222 |
| Diazepam | 22 | $105 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Rochester
- Jonathan FinnoffRochester$9K
- Michael WainbergRochester$5K
- Sandra OgletreeRochester$5K
- Billie SchultzRochester$2K
- Bradford LandryRochester$2K
- Augustus EvangelistaRochester$2K
- Allen BrownRochester$1K
- James MeilingRochester$717
- Jay SmithRochester$523
- Subha HanifRochester$382
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.